» Articles » PMID: 21779436

Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s)

Overview
Journal Genes Cancer
Specialty Oncology
Date 2011 Jul 23
PMID 21779436
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

Most genetic changes that promote tumorigenesis involve dysregulation of G1 cell cycle progression. A key regulatory site in G1 is a growth factor-dependent restriction point (R) where cells commit to mitosis. In addition to the growth factor-dependent "R," which maps to a site about 3.5 hours after mitosis, there is another checkpoint later in G1 that is dependent on nutritional sufficiency that has also been referred to as R. However, this second site in late G1 can be distinguished both temporally and genetically from R. We are proposing that the late G1 regulatory site be more appropriately referred to as a "cell growth" checkpoint to distinguish it from R. This checkpoint, which likely has an evolutionary relationship to the yeast cell cycle checkpoint START, is regulated by signals governed by mTOR, the mammalian target of rapamycin. This review summarizes evidence that distinguishes R from the proposed cell growth checkpoint. Since both checkpoints are dysregulated in most, if not all, human cancers, distinguishing between these 2 distinct G1 regulatory checkpoints has significance for rational therapeutic strategies targeting oncogenic signals.

Citing Articles

cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling.

Deng H, Rukhlenko O, Joshi D, Hu X, Junk P, Tuliakova A Sci Adv. 2025; 11(1):eado9970.

PMID: 39752487 PMC: 11698091. DOI: 10.1126/sciadv.ado9970.


Pro-apoptotic and anti-proliferative activities of cassane diterpenoids on squamous carcinoma cells: An in vitro and in silico study.

Oriakhi K, Erharuyi O, Orumwensodia K, Essien E, Falodun A, Uadia P Toxicol Rep. 2024; 13:101833.

PMID: 39717850 PMC: 11665704. DOI: 10.1016/j.toxrep.2024.101833.


Modulation of signature cancer-related genes in oral cancer cells (Ca9-22) by anethole treatment: Insights into therapeutic potential.

Hammache M, Benchekroun S, Alamri A, Jalouli M, Yousry A Mohamed M, Boufahja F PLoS One. 2024; 19(12):e0315085.

PMID: 39689117 PMC: 11651572. DOI: 10.1371/journal.pone.0315085.


Decoupled transcript and protein concentrations ensure histone homeostasis in different nutrients.

Chatzitheodoridou D, Bureik D, Padovani F, Nadimpalli K, Schmoller K EMBO J. 2024; 43(21):5141-5168.

PMID: 39271795 PMC: 11535423. DOI: 10.1038/s44318-024-00227-w.


M--M mediated denaturation resistant P2 tetramer on the infected erythrocyte surface of malaria parasite imports serum fatty acids.

Das S, Manna A, Majumdar O, Dhara L iScience. 2024; 27(5):109760.

PMID: 38726364 PMC: 11079477. DOI: 10.1016/j.isci.2024.109760.


References
1.
Sherr C, McCormick F . The RB and p53 pathways in cancer. Cancer Cell. 2002; 2(2):103-12. DOI: 10.1016/s1535-6108(02)00102-2. View

2.
Stiles C, Capone G, Scher C, Antoniades H, Van Wyk J, Pledger W . Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A. 1979; 76(3):1279-83. PMC: 383234. DOI: 10.1073/pnas.76.3.1279. View

3.
Pardee A . A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A. 1974; 71(4):1286-90. PMC: 388211. DOI: 10.1073/pnas.71.4.1286. View

4.
Shi M, Zheng Y, Garcia A, Xu L, Foster D . Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Lett. 2007; 258(2):268-75. PMC: 3618667. DOI: 10.1016/j.canlet.2007.09.003. View

5.
Gille H, Downward J . Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem. 1999; 274(31):22033-40. DOI: 10.1074/jbc.274.31.22033. View